Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Patterson, BO; Hinchliffe, R; Loftus, IM; Thompson, MM; Holt, PJ (2010)
Languages: English
Types: Article
Deep vein thromboses (DVTs) cause significant morbidity and mortality in the general population. Oral anticoagulation therapy may reduce thrombus propagation but does not cause clot lysis and therefore does not prevent postthrombotic syndrome (PTS). Catheter-directed thrombolysis (CDT) can be used to treat DVTs as an adjunct to medical therapy, but there is no consensus defining exact indications. Current evidence suggests that CDT can reduce clot burden and DVT recurrence and consequently prevents the formation of PTS compared with systemic anticoagulation. Appropriate indications include younger individuals with acute proximal thromboses, a long life expectancy, and relatively few comorbidities. Limb-threatening thromboses may also be treated with CDT, although the subsequent mortality remains high. A number of randomized controlled trials are currently under way comparing the longer-term outcomes of CDT compared with anticoagulation alone. Initial reports suggest that venous patency and valvular function are better maintained after CDT. The effectiveness of combined pharmacomechanical thrombectomy and the role of vena cava filters need to be investigated further before strong recommendations can be made. The reported short-term outcomes following catheter-based intervention for DVT are encouraging in selected patients. Further evidence is required to establish long-term benefits and cost-effectiveness.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756 -764.
    • 2. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141:249 -256.
    • 3. Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Ginsberg JS. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6:1105-1112.
    • 4. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, on behalf of the Subcommitee on the Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879 - 838.
    • 5. Weaver F, Meacham P, Adkins R, Dean R. Phlegmasia cerulea dolens: therapeutic considerations. South Med J. 1998;81:306 -312.
    • 6. Kahn S, Ginsberg J. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev. 2002;16: 155-165.
    • 7. Buller H, Agnelli G, Hull R, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembloic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401S- 428S.
    • 8. Meissner AJ, Misiak A, Ziemski JM, Scharf R, Rudowski W, Huszcza S Kucharski W, WisÅ‚awski S. Hazards of thrombolytic therapy in deep vein thrombosis. Br J Surg. 1987;74:991-993.
    • 9. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg. 1993;36:359 -364.
    • 10. Schweiter J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L, Graf A. Short and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36:1343.
    • 11. Watson L, Armon M. Thrombolysis for acute deep venous thrombosis. Cochrane Database Syst Rev. 2007;18:Art No. CD002783.
    • 12. Protack C, Bakken A, Patel N, Saad W, Waldman D, Davies M. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg. 2007;45:992-997.
    • 13. Enden T, Klow NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM. CaVenT study group. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost. 2009;7:1268 -1275.
    • 14. Baekgaard N, Broholm R, Just S, Jorgensen M, Jensen L. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39: 112-117.
    • 15. Kearon C, Kahn S, Agnielli G, Goldhaber S, Raskob G, Comerota A. Antithrombotic therapy for venous thromboembolic disease: Am College of Chest Physicians evidence based clinical practice guidelines (8th edition). Chest. 2008;133:454S-545S.
    • 16. Comerota AJ. The ATTRACT trial: rationale for early intervention for iliofemoral DVT. Perspect Vasc Surg Endovasc Ther. 2010 Jan 3 [E-pub ahead of print].
    • 17. Enden T, Sandvik L, Klow N, Hafsahl G, Holme PA, Holman LO Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM. Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis: the CaVenT study: rationale and design of a multicentre, randomized controlled, clinical trial (NCT00251771). Am Heart J. 2007;154: 808 - 814.
    • 18. Segal J, Streiff M, Hofmann L, Thornton K, Bass E. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007;146:211-222.
    • 19. Meissner M. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Rev Cardiovasc Med. 2002;3:S53-S60.
    • 20. Mewissen M. Catheter-directed thrombolysis for lower extremity deep vein thrombosis. Tech Vasc Interv Radiol. 2001;4:111-114.
    • 21. McLafferty R. Endovascular management of deep venous thrombosis. Perspect Vasc Surg Endovasc Ther. 2008;20:87-91.
    • 22. Strandness D Jr, Langlois Y, Cramer M, Randlett A. Long-term sequelae of acute venous thrombosis. JAMA. 1983;250:1289 -1292.
    • 23. Comerota A, Schmieder F. Intraoperative lytic therapy: agents and methods of administration. Semin Vasc Surg. 2001;14:132-142.
    • 24. Mewissen M, Seabrook G, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39 - 49.
    • 25. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dieta CA Jr, Caldwell MD Key NS, Hirsch AT, Hunter DW. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405- 418.
    • 26. Kibbe M, Ujiki M, Goodwin A, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004;39:937-943.
    • 27. Heniford B, Senler S, Olsofka J, Carrillo E, Bergamini T. May-Thurner syndrome: management by endovascular surgical techniques. Ann Vasc Surg. 1998;12:482- 486.
    • 28. Kim J, Choi D, Guk Ko Y, Park S, Jang Y, Lee do Y. Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome. Cardiovasc Intervent Radiol. 2006;29:571-575.
    • 29. Kwak H, Han Y, Lee Y, Jin G, Chung G. Stents in common iliac vein obstruction with acute ipsilateral deep thrombosis: early and late results. J Vasc Interv Radiol. 2005;16:815- 822.
    • 30. Husmann M, Heller G, Kalka C, Savolainen H, Do D, Schmidli J. Stenting of common iliac vein obstructions combined with regional thrombolysis and thrombectomy in acute deep vein thrombosis. Eur J Vasc Endovasc Surg. 2007;34:87-91.
    • 31. Burroughs K. New considerations in the diagnosis and therapy of deep vein thrombosis. South Med J. 1999;92:517-520.
    • 32. Rao A, Konig G, Leers SA, Cho J, Rhee RY, Makaroun MS, Chaer RA. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis. J Vasc Surg. 2009;50:1092-1098.
    • 33. Gandini R, Maspes F, Sodani G, Masala S, Assegnati G, Simonetti G. Percutaneous ilio-caval thrombectomy with the Amplatz device: preliminary results. Eur Radiol. 1999;9:951-958.
    • 34. Elsharawy M, Elzayat E. Early results of thrombolysis vs. anticoagulation in iliofemoral venous thrombosis: a randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24:209 -214.
    • 35. Jackson L, Wang X, Dudrick S, Gersten G. Catheter directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis. Am J Surg. 2005;190:864 - 868.
    • 36. Lin P, Zhou W, Dardik A, Mussa F, Kougias P, Hedayati H. Catheterdirect thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006;192:782-788.
    • 37. Shi H, Huang Y, Shen T, Xu Q. Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of symptomatic lower extremity deep venous thrombosis. Eur J Radiol. 2009;71: 350 -355.
    • 38. O'Sullivan GJ, Semba CP, Bittner CA, Kee ST, Razavi MK, Sze DY, Dake MD. Endovascular management of iliac vein compression (MayThurner) syndrome. J Vasc Interv Radiol. 2000;11:823- 836.
    • 39. Patel NH, Stookey KR, Ketcham DB, Cragg AH. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interv Radiol. 2000;11:1297-1302.
    • 40. Heijmen RH, Bollen TL, Duyndam DA, Overtoom TT, Van Den Berg JC, Moll FL. Endovascular venous stenting in May-Thurner syndrome. J Cardiovasc Surg (Torino). 2001;42:83- 87.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article